Αρχική World News Opinion: ‘Beating cancer means beating it for everyone’

Opinion: ‘Beating cancer means beating it for everyone’

Two women talking.

Cancer doesn’t exist in a vacuum. The factors that determine which groups in society face the greatest burden also have a role to play in who’s most likely to get cancer, and to die from it. These factors are complex, they are deeply woven into the fabric of our society – and they can’t be ignored.

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, and I have a long-held interest in Equality, Diversity and Inclusion. But the events of the past year brought issues of inequality into sharp focus, and that in turn focused our minds. In June we published our initial commitments, which included a commitment to becoming an organisation committed to EDI, and that we would develop a short-, medium- and long-term plan for how to get there.

I’m proud to be launching that strategy today. This marks a significant step forward for us as a charity, for our community and for our collective fight against cancer.

Michelle Mitchell, chief executive officer of Cancer Research UK.

Michelle Mitchell is Cancer Research UK’s chief executive.

Cancer Research UK is the largest funder of cancer research in the world. So we have a responsibility to make sure our research community is inclusive, diverse and thriving.

38 million people each year access health information developed by Cancer Research UK. So we must ensure that it is easy to access and easy to understand, for everyone.

We are a voice for people affected by cancer in the media, and to Governments. We have a responsibility to highlight where there are inequalities, and use our voice and our partnerships to make sure they’re tackled.

We’re a large organisation, employing 3,500 people and supported by 30,000 volunteers. Every person at Cancer Research UK needs to be supported to do their best work, we need to have a breadth of skills and experiences and the best leaders who also represent the communities we serve.

This strategy sets out the actions we’re taking to meet these responsibilities. We want to create a charity where everyone feels like they belong, benefits from, and participates in the work we do.

This means becoming an anti-racist charity, challenging racism and discrimination whenever we encounter it in the scope of our work.

I’m proud of the progress we’ve already made over the past few years. We’ve doubled female membership on research committees, addressed a lack of diversity in clinical trials and published a report on socioeconomic inequalities in cancer.

But we’ve also made mistakes. We could’ve done more to tackle racial biases in academic research, had a stronger voice on health inequalities, and acted quicker to make sure that our communications materials reflected the diversity of our community.

By publishing this plan, I want to make a public commitment to change for the better. We will share our progress each year, be transparent where we haven’t got it right, and always be open to learning. Because while this is a great step forward for Cancer Research UK, it is not the final step –we have to fulfil these commitments, learn as we go and in parallel, look towards our longer-term ambitions for change. As chief executive, I am personally committed to this and will be leading this change.

Michelle Mitchell is the chief executive of Cancer Research UK

Read more:

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Քաղցկեղն իմ համայնքում՝ Քաղցկեղով երեխաների բուժումը Հայաստանում

«Քաղցկեղն իմ համայնքում»-ը Cancer.Net Blog շարքից է, որը ցույց է տալիս աշխարհում քաղցկեղի ազդեցությունը և թե ինչպես են մարդիկ աշխատում իրենց տարածաշրջանում քաղցկեղով մարդկանց...

Ovarian cancer screening trial did not save lives

“The effort from the start was to save lives of women with ovarian cancer. To build evidence for a screening programme that the NHS...

Cemiplimab Outperforms Investigator’s Choice Chemotherapy in the Second-Line Setting for Recurrent/Metastatic Cervical Carcinoma

Overall survival (OS) was significantly improved with cemiplimab as compared to investigator’s choice of chemotherapy in patients with recurrent/metastatic cervical cancer and progression after...

Expressive Writing, What is It?

One of psychotherapy’s main beliefs is that putting thoughts and feelings into words may produce mental health benefits. Of course, this also applies to cancer...

Sacituzumab Govitecan Earns Full Approval for Triple-Negative Breast Cancer

May 12, 2021, by NCI Staff In triple-negative breast cancer (TNBC), tumor cells don't have estrogen receptors (ER), progesterone receptors (PR), or large amounts of...

‘Will cancer make me infertile?’ – That Cancer Conversation

For the first episode of That Cancer Conversation, we explore infertility and cancer. From teenage body worries to an intercontinental surrogacy story, we chat to...